person

Thomas D.

Country
France
Department
Centre Mémoire Ressources et Recherche (CMRR)

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
111
Sites with multiple studies

Has run more than one trial at 111 of 162 partner sites.

Specializations

Neurodegenerative Disorders

The investigator specializes in early and preclinical Alzheimer's disease, with particular focus on innovative therapeutic approaches targeting tau proteins and cognitive decline prevention.

  • Tau-targeted immunotherapy
  • Cognitive decline assessment
  • Disease progression monitoring

Their research extends to evaluating novel compounds that may influence the trajectory of early-stage neurodegeneration.

Psychiatric Conditions

The investigator focuses on treatment-resistant depression in elderly populations and psychosis associated with Alzheimer's disease, exploring innovative therapeutic interventions.

  • Geriatric depression management
  • Psychosis treatment approaches
  • Novel therapeutic compounds

Their work encompasses both acute symptom management and long-term therapeutic solutions for complex neuropsychiatric conditions.

Therapeutic Innovation

The investigator evaluates novel pharmaceutical compounds for neuropsychiatric conditions, including specialized treatments for Alzheimer's-related psychosis.

  • Long-term safety assessment
  • Treatment tolerability studies
  • Therapeutic efficacy evaluation

Their research includes investigating both established and experimental therapeutic approaches for complex neurological conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.